VVOS Annual Retained Earnings
-$93.05 M
-$13.58 M-17.09%
31 December 2023
Summary:
As of January 23, 2025, VVOS annual retained earnings is -$93.05 million, with the most recent change of -$13.58 million (-17.09%) on December 31, 2023. During the last 3 years, it has fallen by -$57.72 million (-163.34%). VVOS annual retained earnings is now -643.01% below its all-time high of -$12.52 million, reached on December 31, 2018.VVOS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VVOS Quarterly Retained Earnings
-$101.36 M
-$2.62 M-2.65%
30 September 2024
Summary:
As of January 23, 2025, VVOS quarterly retained earnings is -$101.36 million, with the most recent change of -$2.62 million (-2.65%) on September 30, 2024. Over the past year, it has dropped by -$8.31 million (-8.93%). VVOS quarterly retained earnings is now -335.43% below its all-time high of -$23.28 million, reached on December 31, 2019.VVOS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VVOS Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.1% | -8.9% |
| 3 y3 years | -163.3% | -110.2% |
| 5 y5 years | -643.0% | -161.7% |
VVOS Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.3% | at low | -82.2% | at low |
| 5 y | 5-year | -299.7% | at low | -335.4% | at low |
| alltime | all time | -643.0% | at low | -335.4% | at low |
Vivos Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$101.36 M(+2.6%) |
| June 2024 | - | -$98.74 M(+2.0%) |
| Mar 2024 | - | -$96.81 M(+4.0%) |
| Dec 2023 | -$93.05 M(+17.1%) | -$93.05 M(+4.8%) |
| Sept 2023 | - | -$88.79 M(+2.4%) |
| June 2023 | - | -$86.70 M(+6.8%) |
| Mar 2023 | - | -$81.17 M(+2.1%) |
| Dec 2022 | -$79.47 M | -$79.47 M(+8.3%) |
| Sept 2022 | - | -$73.38 M(+8.0%) |
| June 2022 | - | -$67.95 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$61.14 M(+9.9%) |
| Dec 2021 | -$55.62 M(+57.4%) | -$55.62 M(+15.3%) |
| Sept 2021 | - | -$48.23 M(+12.7%) |
| June 2021 | - | -$42.78 M(+10.4%) |
| Mar 2021 | - | -$38.73 M(+9.6%) |
| Dec 2020 | -$35.34 M(+51.8%) | -$35.34 M(+21.5%) |
| Sept 2020 | - | -$29.09 M(+6.6%) |
| June 2020 | - | -$27.27 M(+17.2%) |
| Dec 2019 | -$23.28 M(+85.9%) | -$23.28 M |
| Dec 2018 | -$12.52 M | - |
FAQ
- What is Vivos Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Vivos Therapeutics?
- What is Vivos Therapeutics annual retained earnings year-on-year change?
- What is Vivos Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly retained earnings year-on-year change?
What is Vivos Therapeutics annual retained earnings?
The current annual retained earnings of VVOS is -$93.05 M
What is the all time high annual retained earnings for Vivos Therapeutics?
Vivos Therapeutics all-time high annual retained earnings is -$12.52 M
What is Vivos Therapeutics annual retained earnings year-on-year change?
Over the past year, VVOS annual retained earnings has changed by -$13.58 M (-17.09%)
What is Vivos Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VVOS is -$101.36 M
What is the all time high quarterly retained earnings for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly retained earnings is -$23.28 M
What is Vivos Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VVOS quarterly retained earnings has changed by -$8.31 M (-8.93%)